- Home
- BNL vs LNTH Comparison
BNL vs LNTH Comparison
Compare BNL & LNTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BNL
- LNTH
- Stock Information
- Founded
- BNL 2007
- LNTH 1956
- Country
- BNL United States
- LNTH United States
- Employees
- BNL N/A
- LNTH N/A
- Industry
- BNL Real Estate Investment Trusts
- LNTH Biotechnology: In Vitro & In Vivo Diagnostic Substances
- Sector
- BNL Real Estate
- LNTH Health Care
- Exchange
- BNL Nasdaq
- LNTH Nasdaq
- Market Cap
- BNL 3.5B
- LNTH 3.8B
- IPO Year
- BNL 2020
- LNTH 2015
- Fundamental
- Price
- BNL $18.12
- LNTH $51.19
- Analyst Decision
- BNL Buy
- LNTH Buy
- Analyst Count
- BNL 7
- LNTH 6
- Target Price
- BNL $19.71
- LNTH $74.50
- AVG Volume (30 Days)
- BNL 1.7M
- LNTH 1.4M
- Earning Date
- BNL 10-29-2025
- LNTH 11-06-2025
- Dividend Yield
- BNL 6.44%
- LNTH N/A
- EPS Growth
- BNL N/A
- LNTH N/A
- EPS
- BNL 0.47
- LNTH 2.39
- Revenue
- BNL $447,973,000.00
- LNTH $1,525,933,000.00
- Revenue This Year
- BNL $5.32
- LNTH N/A
- Revenue Next Year
- BNL $6.30
- LNTH $1.98
- P/E Ratio
- BNL $38.38
- LNTH $21.34
- Revenue Growth
- BNL 5.49
- LNTH 1.95
- 52 Week Low
- BNL $13.96
- LNTH $47.25
- 52 Week High
- BNL $18.87
- LNTH $111.29
- Technical
- Relative Strength Index (RSI)
- BNL 44.27
- LNTH 36.35
- Support Level
- BNL $17.82
- LNTH $54.76
- Resistance Level
- BNL $18.17
- LNTH $61.92
- Average True Range (ATR)
- BNL 0.33
- LNTH 2.36
- MACD
- BNL -0.07
- LNTH -0.44
- Stochastic Oscillator
- BNL 34.70
- LNTH 4.15
About BNL Broadstone Net Lease Inc.
Broadstone Net Lease Inc is an internally managed real estate investment trust that invests in, owns, and manages single-tenant commercial real estate properties that are net leased on a long-term basis to a diversified group of tenants. The company has selectively invested in net leased assets in the industrial, healthcare, restaurant, retail, and office property types. The company focuses on investing in real estate that is operated by creditworthy single tenants in industries characterized by positive business drivers and trends. The company targets properties that are an integral part of the tenants' businesses and are therefore opportunities to secure long-term net leases.
About LNTH Lantheus Holdings Inc.
Lantheus Holdings Inc caters to the United States healthcare sector with the development of diagnostic products. Its products are in three categories: Precision Diagnostics, Radiopharmaceutical Oncology, and Strategic Partnerships and Other Revenue. Precision Diagnostic products assist healthcare professionals Find and Follow diseases, with a focus in cardiology. Radiopharmaceutical Oncology diagnostics and therapeutics help HCPs Find, Fight and Follow cancer. Strategic Partnerships focus on enabling precision medicine through the use of biomarkers, digital solutions and pharma services platforms, and also includes license of RELISTOR to Bausch Health Companies, Inc.